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ABSTRACT 
 
Background: We hypothesize that racial differences in utero contribute to the racial 
disparity in prostate cancer risk. Leptin is a candidate for evaluating this hypothesis 
because it influences fetal development and newborn growth. Methods: We measured 
leptin concentration by ELISA in venous cord blood collected from 70 African-American 
and 37 white male full-term births. We measured sex steroid hormones and insulin-like 
growth factor (IGF) axis concentrations previously. Separately by race, we calculated 
the geometric mean leptin concentration and estimated the geometric mean adjusted for 
birth and placental weights, mother’s age and parity, time of day and season of birth, 
and sex steroid hormone and IGF-axis concentrations using linear regression. Results: 
Leptin was positively correlated with birth (r=0.34) and placental (r=0.25) weights, IGF-1 
(r=0.21), and IGF binding protein-3 (r=0.29) adjusting for race. Unadjusted geometric 
mean leptin did not differ (p=0.92) between African Americans (5,280 pg/mL; 95% CI: 
4,322-6,451) and whites (5,187 pg/mL; 95% CI: 3,938-6,832). Adjusted geometric mean 
leptin was nonstatistically significantly higher (p=0.15) in African Americans (5,954 
pg/mL; 95% CI: 4,725-7,502) than whites (4,133 pg/mL; 95% CI: 2,890-5,910). 
Conclusion: We observed a non-significantly higher adjusted cord blood leptin 
concentration in African-American compared with white male babies, although 
unadjusted levels were similar.  
Impact: These findings do not support the hypothesis that leptin level in utero 
contributes to the racial disparity in prostate cancer risk in adulthood. 
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INTRODUCTION 
 In the US, African-American men have 1.6-times the incidence of and 2.4-times 
the mortality from prostate cancer compared with white men (1). Reasons for this 
disparity are unclear, but may include racial variation in dietary and lifestyle factors, 
health-seeking and treatment behaviors, and genetic susceptibility (2). This disparity 
remains after taking into account racial differences in the prevalence of exposures in 
middle age (3). That racial differences in exposures experienced in middle age do not 
appear to fully explain the disparity in prostate cancer rates supports investigating 
whether racial differences in exposures earlier in life may be explanatory. 
Evidence is emerging that risk of chronic diseases (4), including cancer (5, 6), in 
adulthood may be influenced by the in utero environment. For example, in some studies 
higher birth weight, a marker for in utero development, has been reported to be 
associated with an increased risk of prostate cancer especially advanced stage disease 
(7-11). This observation suggests that growth-related factors in utero contribute to 
prostate carcinogenesis and may also influence the progression of the disease to a 
worse phenotype. Based on these findings, we hypothesize that racial differences in in 
utero factors, especially those that influence fetal development and newborn growth, 
may contribute to the observed racial disparity in prostate cancer.  
Given our prior findings that African-American male babies had a higher molar 
ratio of testosterone to sex hormone binding globulin (SHBG) but lower concentrations 
of IGF-1 and IGF-2 in umbilical cord blood than white male babies (12), the hormone 
leptin was next of interest to us because of its role in fetal development and newborn 
growth (13). In adults, leptin, which is produced by adipose tissue, regulates energy 
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intake and expenditure (14). Relevant to racial disparities, circulating leptin levels were 
higher in African-American than white men taking into account differences in adiposity in 
a US nationally representative study (15). Although laboratory-based studies have 
shown that leptin promotes prostate cancer cell proliferation and angiogenesis (16), 
adult leptin levels have not been consistently associated with prostate cancer risk (17-
21).  
Relevant to the in utero environment, both fetal adipose tissue and the placenta 
produce leptin, and some fetal tissues and the placenta express the leptin receptor, 
suggesting an important role for leptin in the maintenance of pregnancy and fetal 
development (13, 22). In addition, in utero leptin levels may influence newborn growth 
via effects on the hypothalamus, which in turn may influence appetite regulation after 
birth and energy balance in adult life (23). Children who experience catch-up growth 
have been reported later in life to have a higher risk of obesity and the metabolic 
syndrome (24-26), both of which are risk factors for more aggressive prostate cancer in 
some studies (27). 
Whether racial differences in leptin levels in utero exist and could, in part, explain 
the racial disparity in prostate cancer has not been addressed. Among the few studies 
that have evaluated differences in cord blood leptin concentrations between racial or 
ethnic groups (28, 29), none that we are aware of has compared cord blood leptin levels 
in African American and whites. African-American babies have a lower mean birth 
weight and a higher proportion of low and very low birth weight compared with white 
babies (30). Yet, African Americans have been reported to grow faster in childhood and 
early adolescence (31). While birth weight itself may not directly explain the higher risk 
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of prostate cancer in African-American men, in utero leptin levels could indirectly 
influence the risk of prostate cancer later in life through newborn or childhood catch-up 
growth. To begin to address this hypothesis, we evaluated whether venous umbilical 
cord blood leptin concentration differs between African-American and white male babies.  
 
METHODS 
We used data and samples from the Hormones in Umbilical Cord Blood (HUB) 
Study; we reported details previously (12). The HUB Study was approved by the 
Institutional Review Boards (IRB) of the Prince George’s Hospital Center and the Johns 
Hopkins Bloomberg School of Public Health. Evaluation of the leptin hypothesis using 
the HUB samples was approved by the Johns Hopkins Bloomberg School of Public 
Health IRB. 
We collected venous umbilical cord blood samples from births that met inclusion 
criteria at two hospitals, Prince George’s Hospital Center in Cheverly, MD (Hospital 1) 
and the Johns Hopkins Hospital in Baltimore, MD (Hospital 2), between February 2004 
and June 2005. Delivery room nurses collected the cord blood samples and 
demographic data. Inclusion criteria for the babies were full-term birth (38th-42nd 
gestational week), normal birth weight (2,500-4,000 g), no major birth defects, and 
singleton birth. Inclusion criteria for the mothers were no pregnancy complications (e.g., 
gestational or pre-gestational diabetes mellitus, gestational or chronic hypertension, or 
thyroid diseases); no use of hormonal medications during pregnancy; and no known 
growth hormone deficiency. Also, the baby’s mother and father were required to be of 
the same race. 
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For each eligible birth, the delivery room nurses used a standardized form to 
collect the following maternal and birth-related data: month and time (quadrant) of day 
of the birth, birth and placental weights, mother/child’s race, and mother’s age, parity 
(number of live births), and gravidity (number of pregnancies). The identities of the 
mothers and their babies were not recorded and no other information was collected. 
Fifteen milliliters of blood in total were collected into two tubes containing sodium EDTA 
from the umbilical cord vein. The samples were temporarily stored in a refrigerator and 
were usually processed within 12 hours. After centrifugation for 15 min at 2,400 rpm at 
room temperature, plasma, buffy coat, and red cells were aliquotted into cryovials and 
stored at -70°C. 
The samples were randomly ordered for shipment and testing. Blinded quality 
control replicates of cord blood samples (n=6) were included to assess assay reliability. 
The plasma samples were shipped on dry ice by overnight courier to the laboratory of 
Dr. Nader Rifai at Children’s Hospital Boston, MA. One hundred thirteen eligible male 
specimens were collected, 75 African Americans and 38 whites. After excluding 6 
specimens missing on covariate data, the final analytic sample was 70 African 
Americans and 37 whites. 
 Leptin concentration was measured using an ultra-sensitive, enzymatically 
amplified, two-step sandwich-type immunoassay (R&D Systems, Minneapolis, MN). 
Laboratory technicians were blinded to race and hospital information. The lowest 
detection limit of the assay was 7.8 pg/mL. The coefficient of variation for the quality 
control specimens was 7.9%. Testosterone, estradiol, and SHBG were measured 
previously in the laboratory of Dr. Nader Rifai, Children’s Hospital Boston, and IGF-1, 
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IGF-2, and IGFBP-3 were measured previously in the laboratory of Dr. Michael Pollak, 
Jewish General Hospital and McGill University (12). 
Because leptin concentration was not normally distributed, we calculated the 
unadjusted geometric mean concentration and tested for a difference in concentration 
between the two racial groups using the t-test. To reduce possible confounding by the 
maternal and birth characteristics and the previously measured analytes, we evaluated 
whether the geometric means differed by race after adjusting for birth (continuous) and 
placental (continuous) weights, mother’s age (continuous) and parity (indicator 
variables), time of day (indicator variables), season of birth (indicator variables), 
testosterone, estradiol, and SHBG (all indicator variables), and IGF-1, IGF-2, and IGF 
binding protein (BP)-3 (all indicator variables) using linear regression models. We tested 
for the difference in the prevalence of high leptin concentration (>10,000 pg/mL) 
between the racial groups using the Cochran-Mantel-Haenszel test. All analyses were 
conducted using SAS version 9.1 (SAS Institute, Cary, NC). 
 
RESULTS 
 Characteristics of the mothers and their male babies are shown in Table 1. 
Compared with white mothers, African-American mothers were, on average, four years 
younger and were less likely to be nulliparous. Mean birth and placental weights were 
lower for African-American compared with white babies. Comparing African-American 
births between the two hospitals, mothers at Hospital 2 were more likely to be 
nulliparous and the distribution of the season, and time of day of birth differed. 
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 Cord blood leptin concentration ranged from 354 to 75,333 pg/mL. Comparing 
cord blood leptin concentrations >10,000 pg/mL (the approximate 80th percentile) to at 
or below, the mothers were slightly older and were more likely to be multiparous and the 
birth and placental weights were slightly higher (data not shown). Leptin concentration 
was statistically significantly positively correlated with birth and placental weights, and 
concentrations of IGF-1, and IGFBP-3 adjusting for race (Table 2). In white babies, 
leptin concentration was positively correlated with birth weight and SHBG. In African-
American babies, leptin was positively correlated with birth weight, placental weight, 
IGF-1, and IGFBP-3. 
 Median (inter-quartile range) cord blood leptin concentrations were 5,249 (3,443-
9,579) and 4,999 (3,297-7,058) pg/mL in African-American and white male babies, 
respectively. Geometric mean cord blood leptin concentration (p=0.92) did not differ 
between African-American (5,280 pg/mL; 95% CI: 4,322-6,451) and white (5,187 pg/mL; 
95% CI: 3,938-6,832) male babies (Table 3). The prevalence of a high leptin 
concentration (>10,000 pg/mL) did not differ between African-American (22.9%) and 
white (18.9%) babies (p=0.64). When we adjusted for maternal and birth characteristics, 
sex steroid hormones, and IGF-axis components simultaneously, cord blood leptin 
concentration was higher (p=0.15) in African Americans (5,954 pg/mL; 95% CI: 4,725-
7,502) compared with whites (4,133 pg/mL; 95% CI: 2,890-5,910). After multivariable 
adjustment, the prevalence of high leptin concentration differed between African-
American and white babies (p<0.01). Adjustment for birth weight and IGFBP-3 
appeared to explain most of the difference between unadjusted and adjusted results 
when entering each maternal factor, birth factor, or other cord blood analytes into the 
9 
model one at a time. The results (data not shown) were similar to overall when 
restricting the analysis to the births at Hospital 2 only, and when restricting to mothers 
20+ years old (the distribution of young maternal age differed by race). 
 
DISCUSSION 
The purpose of this study was to evaluate whether umbilical cord blood leptin 
concentration differs by race, and if so, whether the direction of the difference could 
explain, in part, the observed racial disparity in prostate cancer incidence and mortality 
rates. Cord blood leptin concentration in male babies did not differ by race, although 
after adjustment for maternal and birth characteristics and concentrations of sex steroid 
hormones and IGF-axis components, leptin concentration appeared to be higher in 
African-Americans than whites. If our hypothesis were correct, we would have expected 
differences in cord blood leptin levels between African-American and white male babies 
in the unadjusted analysis as well. 
Prior studies have evaluated racial differences in leptin levels in adulthood and 
childhood. Leptin concentration was similar in African-American and white men in three 
studies (32-34), but in two large studies, African-American men had higher leptin levels 
than white men when taking into account racial differences in body size (15, 35). When 
taking into account body size, leptin concentration was reported to be similar in pre-
pubertal African-American and white children (36, 37) and in infants (38), or lower in 
African-American compared with white children and adolescents (39). Given the 
heterogeneity of the findings on racial variation, it is unclear whether our results for cord 
blood leptin are consistent or inconsistent with prior findings for adults and children. 
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In our study, African American babies had comparable unadjusted leptin levels 
despite their lower birth weight. Because leptin is hypothesized to influence growth after 
birth (23), it is possible that the higher leptin levels for a given birth weight may suggest 
a greater likelihood of catch-up growth among African-American babies compared with 
white babies. Babies who experience catch-up growth have a higher rate of fat gain 
than lean tissue gain (25) and are at an increased risk of diseases such as obesity and 
metabolic syndrome in later life (25, 26). However, whether the phenomenon of catch-
up growth influences prostate cancer risk or influences the racial disparity in risk has yet 
to be evaluated, and no studies have reported low birth weight to be associated with an 
increased risk of prostate cancer (40).  
We considered other possible alternative hypotheses that could account for not 
observing racial differences in cord blood leptin level in the unadjusted analysis. First, 
leptin exposure in utero may not play a role in prostate carcinogenesis and/or it does 
play a role but that it does not influence the racial disparity. Second, measurement of 
leptin in cord blood may not capture the etiologically relevant exposure in utero or the 
timing of when racial differences in leptin levels in utero may exist. Finally, we cannot 
rule out chance as an explanation for the lack of a racial difference in leptin level in the 
unadjusted analysis and/or the non-statistically significantly higher leptin level in African-
Americans in the adjusted analysis.  
To our knowledge, this is the first study to evaluate differences of cord blood 
leptin concentration between African-American and white males. We presented both 
unadjusted and adjusted results because they may lead to differing inferences. 
Unadjusted results reflect the levels experienced by the two racial groups, and if 
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different (barring lack of internal and external validity) could account for the racial 
disparity in prostate cancer risk in the population. In contrast, the adjusted results reflect 
whether there may be racial variation in leptin levels beyond known factors that 
influence leptin levels and that differ by race, including inherent racial differences. We 
were able to adjust for maternal and birth characteristics, sex steroid hormones, and 
components of the IGF-axis, analytes that we previously found to differ by race in the 
cord blood of males (12). However, we did not collect information on the mothers’ diet 
and lifestyle or assess maternal leptin levels during pregnancy. Our study was powered 
to detect moderate or large differences by race in cord blood biomarker concentrations 
(12). Because the sample size for African-American males was larger for white males, 
correlations of similar magnitude were statistically significant in African-Americans, but 
not in whites. 
 Because we conducted the study at only two hospitals, imposed inclusion criteria 
and do not know the proportion of all eligible male births that were included in the study, 
it is unclear whether our cord blood leptin results are generalizable to other births at the 
two hospitals or to US African-American and white male babies. Nevertheless, cord 
blood leptin concentration was in the range previously reported for US babies whose 
birth weight was appropriate for gestational age (41, 42), including in a study of full-term 
African-American babies unselected for birth weight (43). Further, the applicability of our 
results from this contemporary birth cohort to the birth cohorts that are now in the age 
range to be at risk for prostate cancer and that are now experiencing the racial disparity 
is unknown. 
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 In conclusion, we observed no difference in cord blood leptin concentration 
between African-American and white male babies, although after taking into account 
maternal and birth characteristics, sex steroid hormones, and IGF axis components, the 
level was non-statistically significantly higher in African Americans. That African-
American male babies had similar leptin concentration to whites in the unadjusted 
analysis does not support the hypothesis that leptin level in utero contributes to the 
racial disparity in prostate cancer risk in adulthood. 
13 
REFERENCES  
(1) Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 
2010;60:277-300. 
(2) Williams H, Powell IJ. Epidemiology, pathology, and genetics of prostate cancer 
among African Americans compared with other ethnicities. Methods Mol Biol 
2009;472:439-53. 
(3) Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for 
prostate cancer incidence and progression in the Health Professionals Follow-up Study. 
Int J Cancer 2007;121:1571-8. 
(4) Barker DJ. A new model for the origins of chronic disease. Med Health Care 
Philos 2001;4:31-5. 
(5) Ekbom A. Growing evidence that several human cancers may originate in utero. 
Semin Cancer Biol 1998;8:237-44. 
(6) Grotmol T, Weiderpass E, Tretli S. Conditions in utero and cancer risk. Eur J 
Epidemiol 2006;21:561-70. 
(7) Tibblin G, Eriksson M, Cnattingius S, Ekbom A. High birthweight as a predictor of 
prostate cancer risk. Epidemiology 1995;6:423-4. 
(8) Ekbom A, Hsieh CC, Lipworth L, et al. Perinatal characteristics in relation to 
incidence of and mortality from prostate cancer. Br Med J 1996;313:337-41. 
(9) Platz EA, Giovannucci E, Rimm EB, et al. Retrospective analysis of birth weight 
and prostate cancer in the Health Professionals Follow-up Study. Am J Epidemiol 
1998;147:1140-4. 
14 
(10) Nilsen TI, Romundstad PR, Troisi R, Vatten LJ. Birth size and subsequent risk for 
prostate cancer: a prospective population-based study in Norway. Int J Cancer 
2005;113:1002-4. 
(11) Eriksson M, Wedel H, Wallander MA, et al. The impact of birth weight on prostate 
cancer incidence and mortality in a population-based study of men born in 1913 and 
followed up from 50 to 85 years of age. Prostate 2007;67:1247-54. 
(12) Rohrmann S, Sutcliffe CG, Bienstock JL, et al. Racial variation in sex steroid 
hormones and the insulin-like growth factor axis in umbilical cord blood of male 
neonates. Cancer Epidemiol Biomarkers Prev 2009;18:1484-91. 
(13) Forhead AJ, Fowden AL. The hungry fetus? Role of leptin as a nutritional signal 
before birth. J Physiol 2009;587:1145-52. 
(14) Farooqi IS, O'Rahilly S. Leptin: a pivotal regulator of human energy homeostasis. 
Am J Clin Nutr 2009;89:980S-4S. 
(15) Ruhl CE, Everhart JE. Leptin concentrations in the United States: relations with 
demographic and anthropometric measures. Am J Clin Nutr 2001;74:295-301. 
(16) Mistry T, Digby JE, Desai KM, Randeva HS. Obesity and prostate cancer: a role 
for adipokines. Eur Urol 2007;52:46-53. 
(17) Stattin P, Soderberg S, Hallmans G, et al. Leptin is associated with increased 
prostate cancer risk: a nested case-referent study. J Clin Endocrinol Metab 
2001;86:1341-5. 
(18) Baillargeon J, Platz EA, Rose DP, et al. Obesity, adipokines, and prostate cancer 
in a prospective population-based study. Cancer Epidemiol Biomarkers Prev 
2006;15:1331-5. 
15 
(19) Hsing AW, Chua S, Gao YT, et al. Prostate cancer risk and serum levels of 
insulin and leptin: a population-based study. J Natl Cancer Inst 2001;93:783-9. 
(20) Lagiou P, Signorello LB, Trichopoulos D, Tzonou A, Trichopoulou A, Mantozoros 
CS. Leptin in relation to prostate cancer and benign prostatic hyperplasia. Int J Cancer 
1998;76:25-8. 
(21) Stattin P, Kaaks R, Johansson R, et al. Plasma leptin is not associated with 
prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2003;12:474-5. 
(22) Hauguel-de Mouzon S, Lepercq J, Catalano P. The known and unknown of leptin 
in pregnancy. Am J Obstet Gynecol 2006;194:1537-45. 
(23) McMillen IC, Adam CL, Muhlhausler BS. Early origins of obesity: programming 
the appetite regulatory system. J Physiol 2005;565:9-17. 
(24) Claris O, Beltrand J, Levy-Marchal C. Consequences of intrauterine growth and 
early neonatal catch-up growth. Semin Perinatol 2010;34:207-10. 
(25) Dulloo AG. Thrifty energy metabolism in catch-up growth trajectories to insulin 
and leptin resistance. Best Pract Res Clin Endocrinol Metab 2008;22:155-71. 
(26) Levy-Marchal C, Czernichow P. Small for gestational age and the metabolic 
syndrome: which mechanism is suggested by epidemiological and clinical studies? 
Horm Res 2006;65 Suppl 3:123-30. 
(27) Giovannucci E, Michaud D. The role of obesity and related metabolic 
disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 
2007;132:2208-25. 
(28) Yajnik CS, Lubree HG, Rege SS, et al. Adiposity and hyperinsulinemia in Indians 
are present at birth. J Clin Endocrinol Metab 2002;87:5575-80. 
16 
(29) Yeung LP, Wong AC, Wang X, Birmingham CL, Lewicka S, Chanoine JP. 
Different relationship between anthropometric markers and umbilical cord plasma leptin 
in Asian and Caucasian neonates. Pediatr Res 2003;53:1019-24. 
(30) Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2006. Natl Vital 
Stat Rep 2009;57. 
(31) Komlos J, Breitfelder A. Differences in the physical growth of US-born black and 
white children and adolescents ages 2-19, born 1942-2002. Ann Hum Biol 2008;35:11-
21. 
(32) Donahue RP, Zimmet P, Bean JA, et al. Cigarette smoking, alcohol use, and 
physical activity in relation to serum leptin levels in a multiethnic population: The Miami 
Community Health Study. Ann Epidemiol 1999;9:108-13. 
(33) DeLellis Henderson K, Rinaldi S, Kaaks R, Kolonel L, Henderson B, Le 
Marchand L. Lifestyle and dietary correlates of plasma insulin-like growth factor binding 
protein-1 (IGFBP-1), leptin, and C-peptide: the Multiethnic Cohort. Nutr Cancer 
2007;58:136-45. 
(34) Fowke JH, Matthews CM, Buchowski MS, et al. Association between prostate-
specific antigen and leptin, adiponectin, HbA1c or C-peptide among African-American 
and Caucasian men. Prostate Cancer Prostatic Dis 2008;11:264-9. 
(35) Ruhl CE, Everhart JE, Ding J, et al. Serum leptin concentrations and body 
adipose measures in older black and white adults. Am J Clin Nutr 2004;80:576-83. 
(36) Nagy TR, Gower BA, Trowbridge CA, Dezenberg C, Shewchuk RM, Goran MI. 
Effects of gender, ethnicity, body composition, and fat distribution on serum leptin 
concentrations in children. J Clin Endocrinol Metab 1997;82:2148-52. 
17 
(37) Danadian K, Suprasongsin C, Janosky JE, Arslanian S. Leptin in African-
American children. J Pediatr Endocrinol Metab 1999;12:639-44. 
(38) Koo WW, Hammami M, Hockman EM. Developmental variations in plasma leptin, 
leptin soluble receptor and their molar ratio in healthy infants. Nutr J 2007;6:11. 
(39) Ambrosius WT, Compton JA, Bowsher RR, Pratt JH. Relation of race, age, and 
sex hormone differences to serum leptin concentrations in children and adolescents. 
Horm Res 1998;49:240-6. 
(40) Cnattingius S, Lundberg F, Sandin S, Gronberg H, Iliadou A. Birth characteristics 
and risk of prostate cancer: the contribution of genetic factors. Cancer Epidemiol 
Biomarkers Prev 2009;18:2422-6. 
(41) Christou H, Connors JM, Ziotopoulou M, et al. Cord blood leptin and insulin-like 
growth factor levels are independent predictors of fetal growth. J Clin Endocrinol Metab 
2001;86:935-8. 
(42) Mantzoros CS, Rifas-Shiman SL, Williams CJ, Fargnoli JL, Kelesidis T, Gillman 
MW. Cord blood leptin and adiponectin as predictors of adiposity in children at 3 years 
of age: a prospective cohort study. Pediatrics 2009;123:682-9. 
(43) Adkins RM, Klauser CK, Magann EF, et al. Site -2548 of the leptin gene is 
associated with gender-specific trends in newborn size and cord leptin levels. Int J 
Pediatr Obes 2007;2:130-7. 
 
White
Hospital 1 Hospital 2
Hospital 1 & 
2 Hospital 2
African-
American, 
Hospital 1 
vs 2
African-
American 
vs white, 
Hospital 2
African-
American 
vs white
N 33 37 70 37
Mother’s age (years; mean, sd) 24.4 (5.0) 24.0 (7.1) 24.2 (6.2) 28.7 (6.3) 0.77
a
0.004
a
<0.001
a
Baby’s birth weight (g; mean, sd) 3286 (316) 3193 (362) 3237 (342) 3477 (395) 0.26
a
0.002
a
0.001
a
Placental weight (g; mean, sd) 673 (152) 641 (118) 656 (135) 698 (153) 0.33
a
0.08
a
0.15
a
Parity (%)
0 15.2 40.5 28.6 62.2 0.10
b
0.21
b
0.009
b
1 45.5 27 35.7 21.6
2 21.2 13.5 17.1 10.8
3 18.2 18.9 18.6 5.4
Season of birth (%)
Winter 36.4 24.3 30 10.8 <0.001
b
0.05
b
0.04
b
Spring 27.3 73 51.4 67.6
Summer 6.1 0 2.9 10.8
Fall 30.3 2.7 15.7 10.8
Time of day of birth (%)
Midnight, <6 am 3 27 15.7 32.4 <0.001
b
0.20
b
0.001
b
6 am, <noon 42.4 27 34.3 8.1
Noon, <6 pm 51.5 21.6 35.7 24.3
6pm, <midnight 3 24.3 14.3 35.1
a
 T-test
b
 Fisher’s exact test
Table 1. Maternal and birth characteristics by race and hospital, males, HUB Study 2004-2005
African-American p -value
Leptin p -value Leptin p -value Leptin p -value
Mother's age 0 0.98 0.06 0.73 -0.02 0.87
Parity 0.04 0.65 0.19 0.27 -0.04 0.76
Birth weight 0.34 0.0003 0.49 0.0022 0.28 0.02
Placental weight 0.25 0.01 0.23 0.16 0.25 0.04
IGF-1 0.21 0.02 0.1 0.54 0.28 0.02
IGF-2 0.11 0.25 0.19 0.25 0.12 0.32
IGFBP-3 0.29 0.0025 0.22 0.2 0.36 0.0026
Testosterone 0.11 0.25 -0.02 0.89 0.16 0.18
Estradiol -0.07 0.49 0.08 0.65 -0.14 0.24
SHBG 0.03 0.73 0.4 0.01 -0.14 0.25
a
 Spearman correlation coefficients
b
 Adjusted for race
Table 2. Correlations
a
 between umbilical cord blood leptin concentration and maternal 
and birth characteristics, sex steroid hormones, and growth factors, overall and by 
race, males, HUB Study 2004-2005
All
(n=107)
b
White
(n=37)
African-American
(n=70)
Geometric 
mean 95% CI
Geometric 
mean 95% CI
Unadjusted 5,187 3,938-6,832 5,280 4,322-6,451 0.92
Adjusted for
Birth and placental weights, mother’s age and parity, 
season and time of day of birth
4,434 3,209-6,126 5,737 4,621-7,122 0.11
Testosterone, estradiol, SHBG 4,726 3,514-6,357 5,546 4,496-6,842 0.41
IGF-1, IGF-2, IGFBP-3 4,691 3,555-6,189 5,568 4,576-6,776 0.34
Birth and placental weights, mother’s age and parity, 
season and time of day of birth, testosterone, estradiol, 
SHBG
4,046 2,858-5,727 6,021 4,795-7,562 0.1
Birth and placental weights, mother’s age and parity, 
season and time of day of birth, IGF-1, IGF-2, IGFBP-3
4,302 3,081-6,006 5,829 4,684-7,254 0.19
Birth and placental weights, mother’s age and parity, 
season and time of day of birth, testosterone, estradiol, 
SHBG, IGF-1, IGF-2, IGFBP-3
4,133 2,890-5,910 5,954 4,725-7,502 0.15
Table 3. Geometric mean umbilical cord blood leptin concentration (pg/mL) by race, males, HUB Study 2004-2005
White African-American
p -value
